Previous studies have reported a strong association between ITK expression and poor prognosis in lung adenocarcinoma, breast cancer, hepatocellular carcinoma, and lymphoma (Pan et al., 2021; Liu et al., 2019). This evidence concerns the gene ITK and lung adenocarcinoma.